Most neoplastic cells and tumor-associated cells in the TME secrete factors that block the activation of NK cells, such as IL-6, IL-10, IDO, TGF-β, and prostaglandin E2 (PGE2), through downregulating NK cells activating receptors including NKG2D (117). The gene discussed is KLRK1; the disease is neoplasm.